ophthalmologyОфтальмологияOphthalmology in Russia1816-50952500-0845Ophthalmology10.18008/1816-5095-2014-4-26-31ophthalmology-202Research ArticleКЛИНИЧЕСКИЕ И ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯCLINICAL & EXPERIMENTAL RESEARCHФормирование синдрома сухого глаза у больных эндокринной офтальмопатиейDry eye syndrome in thyroid-associated ophthalmopathyБровкинаА. Ф.BrovkinaA. F.СтешенкоО. Н.SteshenkoO. N.steshenko.ol@yandex.ruЖуковаО. Д.ZhukovaO. D.ФГБУ ДПО «Российская медицинская академия последипломного образования» Минздрава России, Баррикадная ул., д. 2 / 1, 123995 Москва, Российская ФедерацияРоссияDepartment of Ophthalmology of Russian Medical Academy of Postgraduate Education, 125993, Barrikadnaya street, 2 / 1. Moscow, Russian Federation.Russian Federation2014140120151142631Copyright © Бровкина А.Ф., Стешенко О.Н., Жукова О.Д., 20152015Бровкина А.Ф., Стешенко О.Н., Жукова О.Д.Brovkina A.F., Steshenko O.N., Zhukova O.D.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.ophthalmojournal.com/opht/article/view/202

Представлен патогенез развития синдрома «сухого» глаза у больных различными формами эндокринной офтальмопатии. Проведена оценка влияния терапии ХИЛОПАРИН-КОМОДом на состояние прекорнеальной слезной пленки у данной группы больных.

Purpose

Purpose: The pathogenesis of keratoconjunctivitis sicca in patients with thyroid eye disease is presented. The influence of therapy by a HYLO-PARIN® on a condition of a tear film in patients with various forms of thyroid eye disease is assessed.

Methods

Methods: 34 eyes (17 patients) with thyroid eye disease were investigated. Dry eye evaluations included Shirmer and Jhones testing, tear film break-up time, corneal fluorescein staining. Patients were treated with HYLOPARIN ® (Ursapharm, Germany).

Results

Results: Study showed that HYLO-PARIN® resulted in marked improvement as assessed by subjective complaints, Schirmer’s test, tear film break-up test.

Conclusion

Conclusion: HYLO-PARIN® provided relief from the signsand symptoms of dry eye syndrome at patients with various forms of thyroid eye disease.

эндокринная офтальмопатиясиндром «сухого» глазаthyroid eye diseasedry eye syndrome.ReferencesThe definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). The ocular surface. 2007; 5 (2): 75‑92.The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). The ocular surface. 2007; 5 (2): 75‑92.Brzheskij V. V., Somov E. E. [Keratoconjunctival xerosis (diagnosis, clinical features, treatment)]. SPb.: Publishing. «Lefty. Saint Petersburg» 2003. (in Russ.).Brzheskij V. V., Somov E. E. [Keratoconjunctival xerosis (diagnosis, clinical features, treatment)]. SPb.: Publishing. «Lefty. Saint Petersburg» 2003. (in Russ.).Bartalena L., Baldeschi L., Dickinson A. J. et al. Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur. J. Endocrinol. 2008;158: 273‑285.Bartalena L., Baldeschi L., Dickinson A. J. et al. Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur. J. Endocrinol. 2008;158: 273‑285.Eckstein A. K., Finkenrath A., Heiligenhaus A., Renzing-Köhler K., Esser J., Krüger C., Quadbeck B., Steuhl K. P., Gieseler R. K. Dry eye syndrome in thyroidassociated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies. ActaOphthalmol. Scand. 2004; 82 (3): 291‑297.Eckstein A. K., Finkenrath A., Heiligenhaus A., Renzing-Köhler K., Esser J., Krüger C., Quadbeck B., Steuhl K. P., Gieseler R. K. Dry eye syndrome in thyroidassociated ophthalmopathy: lacrimal expression of TSH receptor suggests involvement of TSHR-specific autoantibodies. ActaOphthalmol. Scand. 2004; 82 (3): 291‑297.Scofield R. H., Bruner G. R., Harley J. B., Namjou B. Autoimmune thyroid disease is associated with a diagnosis of secondary Sjögren’s syndrome in familial systemic lupus. Ann. Rheum. Dis. 2007;66 (3): 410‑413.Scofield R. H., Bruner G. R., Harley J. B., Namjou B. Autoimmune thyroid disease is associated with a diagnosis of secondary Sjögren’s syndrome in familial systemic lupus. Ann. Rheum. Dis. 2007;66 (3): 410‑413.Scheurer E. D., Harrison R. A., Lee A. R. Update on thyroid eye disease and management. Clinical Ophthalmology 2009;3: 543‑551.Scheurer E. D., Harrison R. A., Lee A. R. Update on thyroid eye disease and management. Clinical Ophthalmology 2009;3: 543‑551.Villani E., Viola F., Sala R., Salvi M., Mapelli C., Curro N., Vannucchi G., Beck-Peccoz P., Ratiglia R. Corneal Involvement in Graves’ Orbitopathy: An In Vivo Confocal Study. Inv.Ophthalmol.Vis.Sci. 2010; 51 (9):4574‑8.Villani E., Viola F., Sala R., Salvi M., Mapelli C., Curro N., Vannucchi G., Beck-Peccoz P., Ratiglia R. Corneal Involvement in Graves’ Orbitopathy: An In Vivo Confocal Study. Inv.Ophthalmol.Vis.Sci. 2010; 51 (9):4574‑8.Brovkina A. F., Astahov Ju. S. [Manual of Clinical Ophthalmology]. Rukovodstvo po klinicheskoj oftal’mologii. Moscow.: Univ. «MIA», 2014. — 960 р. (in Russ.).Brovkina A. F., Astahov Ju. S. [Manual of Clinical Ophthalmology]. Rukovodstvo po klinicheskoj oftal’mologii. Moscow.: Univ. «MIA», 2014. — 960 р. (in Russ.).

The authors declare that there are no conflicts of interest present.